ARTICLE | Company News
GB Therap, Chiesi Farmaceutici SpA deal
February 7, 2005 8:00 AM UTC
GB acquired exclusive worldwide rights to Chiesi's CHF1512 to treat Parkinson's disease (PD), excluding Italy. The compound has completed Phase III trials in Italy. GB plans to start two more Phase I...